Literature DB >> 16917491

A heterozygous frameshift mutation in the V1 domain of keratin 5 in a family with Dowling-Degos disease.

Haihui Liao1, Yiwei Zhao, David U Baty, John A McGrath, Jemima E Mellerio, W H Irwin McLean.   

Abstract

Dowling-Degos disease (DDD) is an autosomal-dominant genodermatosis characterized by reticulate pigmentation of the flexures. By direct DNA sequencing, we have identified a frameshift mutation in exon 1 of KRT5 in the proband from an extended Spanish DDD kindred. Cloning of PCR products confirmed that this was a 2-bp deletion mutation, designated c.442delAG, leading to a premature termination codon in the V1 domain of the K5 polypeptide, designated p.S148fsX30. These data confirm that haploinsufficiency for K5 causes DDD and points to a prominent role for the keratin intermediate filament cytoskeleton within basal keratinocytes in epidermal pigment biology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16917491     DOI: 10.1038/sj.jid.5700523

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  13 in total

Review 1.  Diseases of epidermal keratins and their linker proteins.

Authors:  Jouni Uitto; Gabriele Richard; John A McGrath
Journal:  Exp Cell Res       Date:  2007-04-24       Impact factor: 3.905

2.  Mutations in POGLUT1, encoding protein O-glucosyltransferase 1, cause autosomal-dominant Dowling-Degos disease.

Authors:  F Buket Basmanav; Ana-Maria Oprisoreanu; Sandra M Pasternack; Holger Thiele; Günter Fritz; Jörg Wenzel; Leopold Größer; Maria Wehner; Sabrina Wolf; Christina Fagerberg; Anette Bygum; Janine Altmüller; Arno Rütten; Laurent Parmentier; Laila El Shabrawi-Caelen; Christian Hafner; Peter Nürnberg; Roland Kruse; Susanne Schoch; Sandra Hanneken; Regina C Betz
Journal:  Am J Hum Genet       Date:  2014-01-02       Impact factor: 11.025

Review 3.  Progress towards genetic and pharmacological therapies for keratin genodermatoses: current perspective and future promise.

Authors:  Jean Christopher Chamcheu; Gary S Wood; Imtiaz A Siddiqui; Deeba N Syed; Vaqar M Adhami; Joyce M Teng; Hasan Mukhtar
Journal:  Exp Dermatol       Date:  2012-07       Impact factor: 3.960

4.  Impact of human pathogenic micro-insertions and micro-deletions on post-transcriptional regulation.

Authors:  Xinjun Zhang; Hai Lin; Huiying Zhao; Yangyang Hao; Matthew Mort; David N Cooper; Yaoqi Zhou; Yunlong Liu
Journal:  Hum Mol Genet       Date:  2014-01-16       Impact factor: 6.150

Review 5.  The molecular basis of human keratin disorders.

Authors:  Meral Julia Arin
Journal:  Hum Genet       Date:  2009-02-27       Impact factor: 4.132

6.  Galli-galli disease: a rare acantholytic variant of dowling-degos disease.

Authors:  J Gomes; J Labareda; I Viana
Journal:  Case Rep Med       Date:  2011-05-05

Review 7.  Disorders of keratinisation: from rare to common genetic diseases of skin and other epithelial tissues.

Authors:  W H Irwin McLean; Alan D Irvine
Journal:  Ulster Med J       Date:  2007-05

8.  Follicular occlusion triad associated with reticulate pigmentary disorder: is there a genetic linkage?

Authors:  Vijay Gandhi; Prashant Verma; Pravesh Yadav
Journal:  Indian J Dermatol       Date:  2013-07       Impact factor: 1.494

9.  The First Report of KRT5 Mutation Underlying Acantholytic Dowling-Degos Disease with Mottled Hypopigmentation in an Indian Family.

Authors:  Shyam Verma; Sandra M Pasternack; Arno Rütten; Thomas Ruzicka; Regina C Betz; Sandra Hanneken
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494

10.  Heterozygous frameshift mutation in keratin 5 in a family with Galli-Galli disease.

Authors:  A K Reisenauer; S V Wordingham; J York; E W J Kokkonen; W H I Mclean; N J Wilson; F J D Smith
Journal:  Br J Dermatol       Date:  2014-06       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.